Hong Kong
· Delayed Price · Currency is HKD CSPC Pharmaceutical Group Statistics
Total Valuation
CSPC Pharmaceutical Group has a market cap or net worth of HKD 59.79 billion. The enterprise value is 50.04 billion.
| Market Cap | 59.79B |
| Enterprise Value | 50.04B |
Important Dates
The next estimated earnings date is Wednesday, November 20, 2024.
| Earnings Date | Nov 20, 2024 |
| Ex-Dividend Date | Oct 31, 2024 |
Share Statistics
CSPC Pharmaceutical Group has 11.65 billion shares outstanding. The number of shares has decreased by -0.51% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 11.65B |
| Shares Change (YoY) | -0.51% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | 24.36% |
| Owned by Institutions (%) | 30.80% |
| Float | 8.06B |
Valuation Ratios
The trailing PE ratio is 10.61 and the forward PE ratio is 9.16. CSPC Pharmaceutical Group's PEG ratio is 1.14.
| PE Ratio | 10.61 |
| Forward PE | 9.16 |
| PS Ratio | 1.81 |
| PB Ratio | 1.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.14 |
Enterprise Valuation
| EV / Earnings | 8.76 |
| EV / Sales | 1.49 |
| EV / EBITDA | 6.22 |
| EV / EBIT | 7.18 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | n/a |
| Interest Coverage | 151.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 11.28% |
| Revenue Per Employee | 1.65M |
| Profits Per Employee | 281,366 |
| Employee Count | 23,500 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.58% in the last 52 weeks. The beta is 0.68, so CSPC Pharmaceutical Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -23.58% |
| 50-Day Moving Average | 5.64 |
| 200-Day Moving Average | 6.04 |
| Relative Strength Index (RSI) | 36.55 |
| Average Volume (20 Days) | 89,012,147 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSPC Pharmaceutical Group had revenue of HKD 33.53 billion and earned 5.71 billion in profits. Earnings per share was 0.48.
| Revenue | 33.53B |
| Gross Profit | 23.67B |
| Operating Income | 7.08B |
| Pretax Income | 7.23B |
| Net Income | 5.71B |
| EBITDA | 8.15B |
| EBIT | 7.08B |
| Earnings Per Share (EPS) | 0.48 |
Balance Sheet
The company has 11.98 billion in cash and 430.72 million in debt, giving a net cash position of 11.55 billion or 0.99 per share.
| Cash & Cash Equivalents | 11.98B |
| Total Debt | 430.72M |
| Net Cash | 11.55B |
| Net Cash Per Share | 0.99 |
| Equity (Book Value) | 40.40B |
| Book Value Per Share | 3.26 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.59%, with operating and profit margins of 21.11% and 17.04%.
| Gross Margin | 70.59% |
| Operating Margin | 21.11% |
| Pretax Margin | 21.56% |
| Profit Margin | 17.04% |
| EBITDA Margin | 24.31% |
| EBIT Margin | 21.11% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 6.17%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 6.17% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 9 |
| Payout Ratio | n/a |
| Buyback Yield | 0.51% |
| Shareholder Yield | 6.67% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on October 15, 2020. It was a forward split with a ratio of 1.6.
| Last Split Date | Oct 15, 2020 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |